Medline, Inc. (MDLN)
47.38
+1.18
(+2.55%)
USD |
NASDAQ |
Feb 06, 11:04
Medline EPS Diluted (Quarterly) : 0.4026 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Abbott Laboratories | 1.017 |
| Enovis Corp. | -9.990 |
| Insulet Corp. | 1.240 |
| AIM ImmunoTech, Inc. | -1.567 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 322.00M |
| Revenue (Quarterly) | 7.115B |
| Total Expenses (Quarterly) | 6.793B |
| Enterprise Value | 52.43B |
| Gross Profit Margin (Quarterly) | 23.87% |
| Profit Margin (Quarterly) | 4.53% |
| Earnings Yield | 3.34% |
| Operating Earnings Yield | 6.24% |
| Normalized Earnings Yield | 3.302 |